Elutia (ELUT) Cash from Operations (2019 - 2026)
Elutia's (ELUT) quarterly Cash from Operations came in at -$8.5 million in Q2 2026, down 2.93% year-over-year from -$8.7 million in Q2 2025, and down 8.15% quarter-over-quarter from -$7.8 million in Q1 2026.
Analysis
Elutia (ELUT) Cash from Operations (2019 - 2026) Analysis & Trends
Elutia has disclosed Cash from Operations across 8 years of filings, most recently posting -$8.5 million for Q2 2026.
- In Q2 2026, Cash from Operations fell 2.93% year-over-year to -$8.5 million; the TTM figure through Jun 2026 stood at -$44.0 million (down 34.18% YoY), while the FY2025 annual figure was -$44.8 million, down 97.78% from the prior year.
- Cash from Operations came in at -$8.5 million for Q2 2026 at Elutia, down from -$7.8 million in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of -$2.4 million in Q2 2023 to a low of -$24.8 million in Q4 2025.
- Average Cash from Operations over 5 years is -$7.5 million, with a median of -$6.4 million recorded in 2022.
- Year-over-year, Cash from Operations slumped 1259.59% in 2022 and jumped 77.67% in 2023.
- Over 5 years, Cash from Operations stood at -$5.2 million in 2022, then plunged by 73.17% to -$9.1 million in 2023, then plunged by 34.94% to -$12.3 million in 2024, then plunged by 102.41% to -$24.8 million in 2025, then surged by 65.86% to -$8.5 million in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were -$8.5 million in Q2 2026, -$7.8 million in Q1 2026, and -$24.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Elutia | 36.01 Mn | 16.11 Mn | 1.45 Mn | -8.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.47 Mn |
| Mar 31, 2026 | -7.83 Mn |
| Dec 31, 2025 | -24.81 Mn |
| Sep 30, 2025 | -2.89 Mn |
| Jun 30, 2025 | -8.23 Mn |
| Mar 31, 2025 | -8.88 Mn |
| Dec 31, 2024 | -12.26 Mn |
| Sep 30, 2024 | -3.43 Mn |
| Jun 30, 2024 | -4.33 Mn |
| Mar 31, 2024 | -2.64 Mn |
| Dec 31, 2023 | -9.08 Mn |
| Sep 30, 2023 | -5.12 Mn |
| Jun 30, 2023 | -2.39 Mn |
| Mar 31, 2023 | -5.17 Mn |
| Dec 31, 2022 | -5.25 Mn |
| Sep 30, 2022 | -5.52 Mn |
| Jun 30, 2022 | -10.70 Mn |
| Mar 31, 2022 | -7.35 Mn |
| Dec 31, 2021 | -6.39 Mn |
| Sep 30, 2021 | -3.10 Mn |